The settlement resolves Lupin’s pending litigation with Astellas and enables the company to continue marketing Mirabegron in the United States
Source :- Companies Read More
August 20, 2026
Lupin settles dispute with Astellas Pharma, keeps Mirabegron sales in US
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
